Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)
- Resource Type
- Source
- Acta Neuropathologica, 139(5), 959-962. Springer Verlag
- Subject
education - Language
- English
- ISSN
- 0001-6322